Neogenix Oncology

Healthcare 📍 Great Neck, United States 👥 1-10 employees 💰 $15.8M raised 📅 Founded 2003

Neogenix Oncology, Inc., a clinical stage biotherapeutic company, focuses on developing novel therapeutic and diagnostic products for the treatment of pancreatic, colon, lung, prostate, and various other cancers. The company’s lead product candidate includes NEO-101 (Ensituximab), a novel Phase IIa monoclonal antibody

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1-10

Total Raised · Venture

$15.8M

Founded

2003

Cloud

Unknown

Email

Mailgun

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Mailgun
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K – $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Neogenix Oncology's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction